= Discovery stage.
= Translation stage.
= Clinically available.
MSACL 2018 EU : Lauc

MSACL 2018 EU Abstract

Keynote Presentation

Self-Classified Topic Area(s): Glycomics

High-throughput Glycomics in Patient Stratification - What Did We Learn from the First 60,000 Analyses


Warning: Undefined variable $headshot in /var/www/html/view_abstract/view_abstract_in_program.php on line 704
 Gordon Lauc (Presenter)
University of Zagreb & Genos Glycoscience Research Laboratory, Zagreb, Croatia

Relevant Financial Disclosures (within past 24 months)
Not yet reported.

Abstract

Since the onset of genome wide association studies, thousands of genetic loci have been associated with different diseases and traits. However, in the last few years it is becoming increasingly clear that variations in a DNA sequence are only a beginning of the understanding of complex human diseases. Genetic polymorphisms have to be put in the context of complex biology of life and a more elaborate approach that combines different ‘omics phenotypes is needed to understand disease mechanisms and perform patient stratification that transcends genomics. Glycomics, as by far the most complex epiproteomic modification, has an immense potential in this respect, which is only beginning to be investigated.